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Brief description – “Novelty and Impact” 
Childhood acute lymphoblastic leukaemia (ALL) is a multi “hit” disease, whereby additional “hits” are 
required to transform pre-malignant cells carrying ALL-associated genetic translocations. We 
investigated the potential that environmental exposures associated with increased ALL risk 
influenced changes in DNA methylation patterns in offspring, and their concordance with 
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 methylation changes identified in ALL disease. We found statistically significant directionally 
concordant changes in methylation for maternal radiation exposure, alcohol, sugary caffeinated 
drinks; and childhood day care attendance. 
Abstract 
The aetiology of childhood acute lymphoblastic leukaemia (ALL) is unclear. Genetic abnormalities 
have been identified in a number of ALL cases, although these alone are not sufficient for leukaemic 
transformation. Various in utero and post-natal environmental exposures have been suggested to 
alter risk of childhood ALL. DNA methylation patterns can be influenced by environmental 
exposures, and are reported to be altered in ALL, suggesting a potential mediating mechanism 
between environment and ALL disease risk. To investigate this, we used a ‘meet in the middle’ 
approach, investigating the overlap between exposure-associated and disease-associated 
methylation change. Genome-wide DNA methylation changes in response to possible ALL-risk 
exposures (i.e. breast feeding, infection history, day care attendance, maternal smoking, alcohol, 
caffeine, folic acid, iron, and radiation exposure) were investigated in a sub-population of the Avon 
Longitudinal Study of Parents and Children (ALSPAC) cohort using an epigenome-wide association 
study (EWAS) approach (n=861-927), and compared to a list of ALL disease-associated methylation 
changes compiled from published data. Hypergeometric probability tests suggested that the number 
of directionally concordant gene methylation changes observed in ALL disease and in response to 
the following exposures; maternal radiation exposure (p=0.001), alcohol intake (p=0.006); sugary 
caffeinated drink intake during pregnancy (p=0.045); and infant day care attendance (p=0.003), were 
not due to chance. Data presented suggests that DNA methylation may be one mediating 
mechanism in the multiple hit pathway needed for ALL disease manifestation.        
Introduction  
Acute lymphoblastic leukaemia (ALL) is the most common form of childhood cancer [1]. Although 
survival rates have improved, with 5-year survival rate increasing from 60-90% [2], overall incidence 
of childhood ALL has been slowly increasing [3]. Genetic aberrations such as chromosomal 
translocations and hyperdiploidy have been suggested to play a role in ALL disease development, yet 
these events alone are not sufficient for disease manifestation. For example, a translocation 
resulting in the TEL-AML1 fusion gene associated with B-cell lineage ALL [4] has been found to be 
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 present in roughly 1% of newborns at birth [5], which is approximately 100-fold higher incidence 
rate than that of childhood B-cell lineage ALL. The peak incidence of childhood ALL, between 2-5 
years of age, suggests that in utero and early life events, including environmental factors, may 
contribute to disease risk. Blood chimerism in twins, occurring via the transfer of hematopoietic 
stem cells between the foetuses, results in concordant twin cases of leukaemia [6]; these have been 
identified as having the same fusion-gene sequence or IGH/TCR sequences, supporting the notion of 
ALL originating in utero. Concordance in identical twins is estimated to be 10%, yet 70% of these 
share the same placenta, suggesting secondary events are required, and have a major impact on the 
likelihood of leukaemia development [7]. Furthermore, a recent study observed spatial clustering of 
ALL cases, using addresses of mothers during pregnancy, suggesting that environmental factors may 
play a role in disease development [8]. Various in utero and early childhood exposures have been 
investigated in the aetiology of childhood ALL [9, 10]. These include breast feeding [11], infection 
history [12], childcare/day care attendance [11, 12], maternal smoking [13, 14], alcohol [15, 16], 
caffeine [15, 17], folic acid [18, 19], iron [20], radiation [8], household paints [21], chemicals [22], 
pesticides [23, 24], and herbicides [25]. The weight of supporting evidence for the role of each 
exposure in the aetiology of childhood ALL varies. The evidence for exposure to pesticides and paints 
demonstrate consistently positive associations with increased risk of childhood leukaemia (including 
data from a recent meta-analysis for paint) [21]. Evidence for a role of maternal caffeine and folate 
intake is weaker, but emerging, with recent meta-analysis suggesting high caffeine intake may be a 
risk factor [17], with folate supplementation suggested to be protective [26]. Despite some evidence 
from earlier studies suggesting maternal smoking and alcohol intake may influence risk, more recent 
meta-analysis found no association between these exposures and childhood leukaemia risk [27]. 
Studies investigating iron intake during pregnancy and leukaemia risk have been small scale and 
therefore are limited in their ability to provide robust evidence [28-30]. Likewise, the number of 
studies investigating maternal and infant radiation exposure is limited, and thus despite associations 
being found between maternal and infant radiation exposure and childhood cancer risk [31, 32], 
further investigations are warranted. A number of studies, including a recent meta-analysis [11], 
suggest that breast feeding and exposure to infection in early life may be protective against 
leukaemia development. 
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 Whilst the strength of the associations for some of these environmental factors and ALL risk is weak 
and evidence limited, this may be due to lack of available environmental data, limited number of 
cases for this rare disease (i.e. studies underpowered), and inaccuracies associated with collecting 
environmental exposure data retrospectively. The investigation of intermediate biomarkers linking 
an exposure and the disease outcome may therefore help to strengthen the evidence for the 
association of a given exposure and disease outcome, but also may offer novel insights into the 
underlying causal pathway to disease.  
Epigenetics play a key role in human health and disease [33-35]. Epigenetic modifications such as 
DNA methylation, the most extensively studied epigenetic modification [36], and alterations to 
chromatic structure are able to modulate gene expression [37]. Methylation of cytosine residues 
located within CpG dinucleotides across the genome play a crucial role in cellular identity by 
inhibiting the binding ability of transcriptomic machinery to DNA, thus influencing gene expression 
[38, 39]. Each individual’s epigenome is subject to change induced via genetic, environmental, and 
stochastic factors throughout the life course [40]. However the epigenome is particularly susceptible 
to dysregulation via environmental influences during gestation, neonatal development, puberty, and 
old age [41]. The establishment of DNA methylation patterns occurs during embryonic development, 
therefore this may be an acutely critical and vulnerable period during which environmental 
influences are of importance for resultant DNA methylation profiles, and possible health 
consequences in later life [42].  
Aberrant DNA methylation in ALL is well established  [39, 43-45], particularly at promoter associated 
CpG islands, which results in hundreds of genes involved in critical molecular pathways being 
silenced [46]. ALL is a heterogeneous disease and is subtyped based on its cellular phenotype and 
cytogenetic aberrations. A core set of CpG sites have been identified as aberrantly methylated 
throughout all subtypes, as well as subtype specific DNA methylation patterns [39, 47].        
As DNA methylation can be altered by environmental exposures, and is known to be altered in ALL 
itself, it is plausible that DNA methylation may act as one potential mediating mechanism via which 
in utero and early life exposures are able to increase the risk of developing ALL. We therefore 
hypothesised that if DNA methylation were a mediating mechanism between environmental risk 
factors and ALL, there would be common methylation changes associated with both a given 
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 exposure and ALL. To investigate this hypothesis we employed a ‘meet in the middle’ approach [48]. 
Firstly, an epigenome-wide association study (EWAS) was carried out to identify associations 
between individual CpG site methylation and ALL risk exposures [49]. Exposure-associated CpG sites 
were mapped to genes and compared with previously identified genes from the literature which 
have reported altered DNA methylation in ALL compared to healthy individuals. Hypergeometric 
testing was used to assess the probability that the resultant overlap between exposure-associated 
and disease-associated methylation was not due to chance. The resultant data suggests that DNA 
methylation may play a mediating role in the causal pathway linking ALL risk exposures with disease 
risk.  
Materials and Methods 
Study population 
The ALSPAC cohort is a prospective birth cohort comprising 14541 pregnancies recruited from the 
Bristol area in England with expected delivery dates between 1st April 1991 and 31st December 
1992 [50, 51]. A large amount of data has been collected including genetic, epigenetic, biological, 
social and other environmental exposures in relation to health and developmental outcomes. Blood 
samples were collected from all consenting mothers (during pregnancy and follow up clinic) and 
their children (birth; childhood, age seven years; and adolescence, age 17 years) at several clinics. 
The study website contains details of all the data that is available through a fully searchable data 
dictionary (http://www.bristol.ac.uk/alspac/researchers/data-access/data-dictionary/). The study 
was observational and aimed to intervene as little as possible in the normal course of pregnancy and 
childhood [52]. Ethical approval for the study was obtained from the ALSPAC Ethics and Law 
Committee and the Local Research Ethics Committees.  
The Accessible Resource for Integrated Epigenomic Studies (ARIES) is a sub-population of the ALSPAC 
cohort [53]. ARIES comprises of 1018 mother child pairs who were selected based on the availability 
of matched-samples at multiple time points required for the study. Genome-wide DNA methylation 
analysis was carried out on blood samples (cord/peripheral) from these individuals at birth and age 
seven. 
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 Identification of environmental factors associated with an increased risk of ALL 
Literature searches were previously carried out to identify exposures associated with ALL risk and 
their potential to influence changes in DNA methylation using the PubMed and ScienceDirect 
databases (1st January 1987- 31st March 2018). This was carried out in three stages, firstly, reviews 
discussing ALL aetiology were screened for environmental exposures potentially associated with 
increased ALL risk. From this initial screen a list of key words were compiled (Box 1). Secondly, a 
more rigorous literature search was carried out using the key words to identify evidence for an 
association between environmental exposures and ALL risk. Thirdly, the identified potential ALL risk 
exposures were used to further investigate the literature to find any relationships between the 
identified exposures and changes in DNA methylation patterns (Box 1). References from these 
papers, including the reviews were also screened. No language restrictions were imposed. To be as 
inclusive as possible in our investigations, we examined all potential risk factors for which there has 
been at least one study providing evidence (even if limited) of an association between an 
environmental factor and ALL risk. 
Box 1. Literature searches carried out, and key words used to identify ALL risk exposures and 
potential exposure associated changes in DNA methylation.  
Literature search Key words 
1. Identification of ALL risk exposures Leukemia, acute lymphoblastic, leukaemia 
2. Identification of evidence supporting an 
association between ALL and an exposure 
Leukemia, acute lymphoblastic, leukaemia, 
radiation, smoking, alcohol, folate, folic acid, 
iron, coffee, caffeine, herbicides, pesticides, 
household chemicals, chemicals, household 
paints, paints, child care, day care, breast 
feeding, birth weight, infection history, 
infection, virus, and bacterial 
3. Identification of relationships between ALL 
risk exposures and changes in DNA methylation 
DNA methylation, and exposures identified in 
literature search 2. 
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 Identification of genes with altered methylation in ALL disease 
Methylation changes in ALL were identified from previously published literature [39, 54], the 
significant CpG sites identified were mapped to genes (see [39, 54] for details). Studies which utilised 
the Illumina Infinium® HumanMethylation450k BeadChip assay (450K BeadChip) to measure DNA 
methylation, were used as they directly correlated with the measurements carried out in the ALSPAC 
cohort. This resulted in a total of 2173 genes which had reported significant differential methylation 
in ALL disease compared to healthy controls (Table S1).  
Additionally, for comparison, a list of gene loci with altered methylation in ALL disease from all large 
published studies [43-45, 55-58], i.e. with no exclusions based on methodologies used to measure 
methylation was also compiled and assessed in relation to variation in methylation observed in 
relation to environmental factors in the ALSPAC cohort.    
Environmental exposure data available in the ALSPAC cohort 
The environmental data used in this study was selected from nine questionnaires carried out as part 
of the ALSPAC study, and these ranged from early gestation, throughout pregnancy, and throughout 
the life of the offspring (still ongoing) (Figure 1). The impact of in utero environmental exposures 
including maternal alcohol intake, smoking, radiation exposure, folic acid supplementation, coffee 
consumption, sugary caffeinated drink consumption and iron supplementation during pregnancy on 
DNA methylation status in offspring cord blood were assessed (Table S2 for cohort characteristics 
and details of measure of exposure variables). No data were available for pesticide exposure, so this 
exposure was not assessed in this analysis. The influence of early life post-natal exposures i.e. day 
care attendance at 8, 38, and 54 months, breast feeding, and offspring reported illness by the 
mothers on DNA methylation in the blood at age seven were also assessed (Table S3). The data used 
in this study was selected to best represent each exposure under investigation (where data were 
available), and in line with previously published data (see Table S4 for summary of evidence and 
indication of risk level, and Table S5 for justification of variable selection). An additional search was 
carried out to identify larger methylation studies (450K BeadChip) which identified exposure 
associated methylation changes (FDR corrected and cell-type adjusted).    
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 Figure 1. Study design: 1a) 450K BeadChip was used to measure DNA methylation in cord blood at 
birth (n = 861); and 1b) in blood age 7 (n = 927); 2) altered DNA methylation in ALL disease identified 
in previous studies [39, 54]; 3a) questionnaires carried out for the ALSPAC study were used to 
identify in utero exposures (8-28 weeks gestation) previously associated with ALL risk (Table S2); and 
3b) post-natal exposures previously associated with ALL risk (8-58 months of age) (Table S3). 
The Illumina Infinium® HumanMethylation450k BeadChip assay, data pre-processing and 
normalisation 
Genome-wide DNA methylation data was previously generated for the ARIES sub-population using 
the 450K BeadChip. The arrays were scanned using an Illumina iScan and reviewed using 
GenomeStudio (version 2011.1). To minimise the possibility of confounding by batch effects, 
samples were semi-randomly arranged on the chip, making sure samples from each time point were 
represented on each chip. Data were pre-processed using R (version 3.0.1) at the MRC Integrative 
Epidemiology Unit, University of Bristol [53]. The WateRmelon package [59] was used according to 
the subset quantile normalisation approach described by Touleimat & Tost [60] to reduce non-
biological differences between probes. Data were normalised using functional normalization [61], 
resulting in a total of 861 cord blood samples and 927 age seven samples for analyses.  
In the cord blood, cell-type proportion estimation was used to adjust for cell type effects. Publicly 
available expression signature data were used, this data can be found in the NCBI Gene Expression 
Omnibus repository, GSE68456 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68456) 
[62]. For the age seven analyses the estimateCellCounts function in the minfi R package [63] was 
used, this is based on the model developed by Houseman et al [64]. The estimated cell-type 
proportion was added to the regression model to adjust for the potential effect of this variable. 
Multiple linear regression analyses of DNA methylation at individual CpG sites and environmental 
factors 
Multiple linear regression analysis was used to investigate associations between DNA methylation at 
individual CpG sites and environmental exposures of interest. For each exposure, the resulting p-
values were corrected for multiple testing by controlling the false discovery rate (FDR) at 5% (p ≤ 
0.05), first described by Benjamini and Hochberg [65]. DNA methylation was modelled as a 
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 continuous variable (outcome), in a multivariate regression model accounting for potential 
confounders (sex, parity, gestation, cell type, and batch). These were selected as relevant covariates, 
as well as being in line with previous multiple linear regression models [66]. 
FDb.InfiniumMethylation.hg19 R package (FDb.InfiniumMethylation.hg19: Annotation package for 
Illumina Infinium DNA methylation probes) was used annotate the methylation data by mapping 
CpG sites to genes for further analyses. If CpG sites were mapped to multiple genes, both genes 
were included in the analyses, and unmappable CpGs were excluded.  
Integration of lists of gene loci with altered methylation due to an ALL risk exposure and a list of 
gene loci with altered methylation in ALL 
Molbiotools (http://www.molbiotools.com/listcompare.html) was used to integrate the list of gene 
loci with altered methylation in ALL, with the lists of gene loci with significantly altered methylation 
(FDR-adjusted p ≤ 0.05) for each ALL risk exposure analysed using the gene symbol for comparison. 
Molbiotools was also used to identify gene loci which overlapped between multiple exposures, as 
well as gene loci which were altered in ALL and multiple exposures. Hypergeometric tests were 
carried out using the GeneProf calculator (http://www.geneprof.org) to assess the probability that 
the observed overlapping changes in methylation found in relation to a given exposure and in ALL 
were likely to be significant (p ≤ 0.05) and not due to a chance observation. An n of 21231 (i.e. the 
number of genes represented on the array) was used as the ‘population size’, with 2173 (i.e. number 
of genes with altered methylation in ALL) as the ‘number of successes in the population’. N used for 
‘sample sizes’ and ‘number of successes in sample’ were the number of genes found to have altered 
methylation in response to a given exposure and the number of genes found to overlap between 
methylation change associated with a given exposure and in ALL respectively. Where larger data sets 
with exposure-associated methylation changes (FDR corrected and cell type adjusted) and disease-
associated methylation changes were available the same integration process discussed above was 
also carried out.     
Gene Ontology enrichment and pathway analysis 
The Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.8 Beta (https://david-
d.ncifcrf.gov/) [67] was used to carry out Gene Ontology (GO) and Kyoto Encyclopaedia of genes and 
genomes (KEGG) pathway analysis to investigate the biological pathways and processes that may be 
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 affected through DNA methylation changes associated with individual in utero and post-natal 
exposures (FDR-adjusted p ≤ 0.05). GO and pathway analysis were carried out for each individual 
exposure using the resultant list of significant genes found to have altered methylation in relation to 
the given exposure. Furthermore, for those exposures where genes were also found to have altered 
methylation in ALL [39, 54], this analysis was also carried out using the list of overlapping genes. 
Results 
Epigenome-wide association study investigating the influence of ALL risk exposures on DNA 
methylation 
For the majority of in utero exposures examined, methylation was found to be significantly altered 
across a range of gene loci in cord blood at birth (FDR-adjusted p ≤ 0.05) (Table 1), with most 
changes observed to be associated with maternal radiation exposure (n CpGs=288), alcohol intake (n 
CpGs=192), and consumption of sugary caffeinated drinks (n CpGs=66) during pregnancy. Only 
maternal iron intake whilst pregnant had no significantly associated methylation changes. The split 
between direction of methylation change in response to radiation and smoking (throughout 
pregnancy, at 3 months, and pre-pregnancy) exposures were roughly equal (i.e. 51% and 55%, 53%, 
43% hypo- and 49% and 45%, 47%, 57% hypermethylated CpGs respectively). Whilst alcohol intake, 
sugary caffeinated drinks, and coffee consumption had larger proportions of hypermethylated 
compared to hypomethylated CpGs (82%, 73% and 60% respectively) (Table 1 and Table S6). Only 
folic acid supplementation resulted in a higher percentage (89%) of hypomethylated CpGs (Table 1 
and Table S6). Gene ontology and pathway analysis carried out for each of the gene lists generated 
for individual in utero exposures only identified one potentially significantly affected pathway 
(‘Amoebiasis’) in response to the methylation changes which occurred in response to radiation 
exposure (Table 2). No other biological processes or pathways were suggested to be affected by 
methylation changes associated with other in utero exposures. Two additional studies were 
identified with larger data sets for maternal smoking (n CpGs=6073 and genes=3176) [68] and 
maternal plasma folate (n CpGs=443 and genes=229) [69] associated methylation changes. Both 
maternal smoking and maternal plasma folate studies had a significant overlap of gene loci with 
exposure associated- and ALL-associated methylation changes (4.95 x 10-11, 4.32 x 10-13, respectively) 
(Table 3). 
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 At age seven, post-natal exposures used as proxy measures for infection i.e. day care attendance (8 
months of age) and maternally reported cold (6 months of age) were found to be significantly 
associated with altered methylation of 11 and 60 gene loci respectively (Table 1). Post-natal 
exposure to day care attendance at 38 months and 54 months, and breast feeding had no 
significantly associated methylation changes. Whilst the direction of methylation change in response 
to day care attendance was approximately equal i.e. 45% hypo- vs 55% hypermethylated CpGs; the 
majority of CpGs with altered methylation in response to having cold symptoms were 
hypomethylated (73%) (Table 1 and Table S6). GO and pathway analysis revealed that methylation 
changes associated with recorded cold exposure may significantly affect the MAPK signalling 
pathway (Table 4), but changes associated with day care attendance and breast feeding were not 
found to be associated with any biological processes or pathways.    
DNA methylation changes in ALL and integration with potential ALL risk exposure associated 
changes in methylation 
Hypergeometric probability tests were used to ascertain if the degree of overlap between 
methylation changes observed in ALL and those associated with a potential risk exposure were 
statistically significant or likely to be due to chance. For over half of the exposures investigated 
(Table 1) there was a significant overlap between genes with both exposure-associated and disease-
associated methylation change.  
The concordance of the change in direction of methylation influenced by exposures and in ALL was 
not uniform across exposures. Whilst concordance was high (i.e. over 70%) for radiation exposure, 
alcohol intake, sugary caffeinated drinks consumption and day care attendance, for all other 
exposures concordance rates were intermediate (smoking and folate supplementation) or even low 
(reported cold symptoms and coffee consumption) (Table 1). We therefore carried out further 
hypergeometric tests to ascertain if the overlap between concordant methylation changes observed 
in ALL and those associated with a potential risk exposure were a statistically significant finding or 
likely to be due to chance (Table S7). These analyses suggested there was a statistically significant 
overlap between genes with methylation change in ALL and those found to have the same direction 
of methylation change in response to in utero exposure to radiation exposure, alcohol intake, sugary 
caffeinated drinks consumption, and to day care attendance at 8 months (Table 1). An unexpected 
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 disparity between findings for maternal coffee and sugary caffeinated drinks consumption have 
been reported in this study. This may allude to something other than caffeine driving the larger 
number of concordant changes identified for sugary caffeinated drinks consumption. The final 
column in Table 1 shows the overlap between genes with exposure-associated changes in 
methylation and changes in methylation in ALL disease from all published studies with no 
restrictions on the methods used to measure methylation. There is a lack of overlap (except for 
radiation exposure associated gene loci) compared to that observed in studies only using the 450K 
BeadChip array. The disparities between studies are likely to be partially or largely driven by the 
differences in technologies used to measure DNA methylation [43-45, 55-58], making the 
comparisons between data sets difficult, therefore this additional analysis should be interpreted 
with care.     
Comparison of the data sets found that 7 gene loci (KCNQ1DN, MAD1L1, ROBO3, SEPT9, SNX8, TBX2 
and ZC3H3) had altered methylation in ALL and in response to more than one potential ALL risk 
exposure, although the direction of methylation change was only found to be conserved between 
ALL and exposures for one gene (TBX2). Pathway analysis did not identify any significantly affected 
pathways when using the lists of genes which had both disease and exposure-associated altered 
methylation, most likely due to an inadequate number of genes overlapping between each exposure 
and ALL disease for this type of analysis or limitation of relying on gene mapping approaches. 
Discussion 
Due to the rarity of childhood ALL it is very difficult to investigate causal pathways in disease 
aetiology. The early onset of disease, with peak incidence between 2-5 years of age, in utero and 
early life periods are likely to be crucial for disease development. Therefore, to improve 
understanding of this complex disease pathway, better knowledge of the differences between 
individuals who possess/experience a first ‘hit’ (e.g. ALL-associated genetic translocation) and 
develop disease, compared to those that do, yet do not develop ALL will be key. However, as such 
genetic abnormalities are rare in the general population (1% for the TEL-AML1 fusion gene [5]), and 
fresh whole blood samples are required to measure such abnormalities, to the best of our 
knowledge, there is currently no single cohort possessing the numbers, data and samples required 
to investigate ALL disease development in this manner. We therefore applied a ‘meet in the middle’ 
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 approach [48] to investigate one plausible mechanism in the disease pathway to link possible risk 
factors to ALL cases i.e. DNA methylation changes.  
We hypothesised that DNA methylation may act as a potential mediating mechanism between 
environmental exposures and childhood ALL risk. The majority of ALL risk exposures investigated in 
this study were shown to influence DNA methylation at multiple gene loci, with some degree of 
overlap found with disease-associated methylation changes. In demonstrating that methylation 
changes associated with these potential risk exposures occur in genes which also have altered 
methylation in overt disease, we provide evidence for a mediating role of DNA methylation in the 
causal disease pathway. Hypergeometeric tests suggest that for over half of the exposures 
investigated (i.e. in utero radiation exposure, maternal alcohol intake, maternal sugary caffeinated 
drinks intake, maternal smoking and infant day care attendance at 8 month), these concomitant 
gene methylation changes were not likely to be due to chance. Moreover, 4/5 of those exposures 
were found to have significant concordant changes in direction of methylation associated with 
exposure and ALL disease (with the exception of maternal smoking). In addition, we also compared 
our ALL-disease associated methylation signature with two previously published studies that 
investigated variation in methylation in association with maternal smoking and plasma folate [68, 
69] (Table 3). This analysis provided additional evidence demonstrating that maternal smoking and 
plasma folate were associated with a large number of methylation changes, and that a significant 
number of these changes were also found in ALL disease. We would therefore suggest that for 
radiation exposure, maternal alcohol intake, maternal sugary caffeinated drinks intake, smoking, and 
folic acid intake, it is plausible that methylation changes which occur as a result of these exposures 
may contribute to the aetiology of ALL.   
Whilst, in this context significant associations were also observed for day care attendance, the causal 
pathway towards disease may be less clear. It has been suggested that infections during early life 
(<1yr) ‘prime’ the immune system, enabling it to elicit an appropriate immune response later in 
childhood and adult life [70]. Without this ‘priming’, it is thought that exposure to infection later in 
life is likely to lead to increased proliferation and error which may lead to the development of 
leukaemia in individuals harbouring genetic aberrations. Greaves [71] suggested a two-hit model for 
role of infections, specifically in B cell precursor ALL. The proposed mechanism is multifactorial, 
involving inherited genetics, modulators of risk (i.e. diet), and exposure to infections in early-life. He 
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 further proposes that developed societies restriction of early-life microbial exposure has led to an 
increase in cases, and may therefore, in-part, be preventable. As such, day care attendance has been 
utilised as a proxy measure for infection, with inverse associations reported between attendance 
and ALL risk [12]. If day care attendance is associated with lower risk of ALL, we would hypothesise 
that DNA methylation changes associated with day care attendance would be protective, and 
therefore show the opposite direction of methylation change to that observed in disease. However, 
here we observed concordant changes across 5/6 genes (i.e. day care related methylation changes 
were associated with ALL risk not protection). Whilst the reason for this perhaps unexpected 
outcome is unclear, there may be several rational explanations for this finding. In this study 
recording of day care attendance was taken at ~8 months. Therefore individuals who attended day 
care thereafter would have been identified as non-attenders. There are therefore likely to have been 
a reasonable proportion of infants who attended day care between the ages of 8 month and 1 year 
i.e. after data collection and prior to usual state nursery attendance schedule, which may have 
influenced DNA methylation patterns of those individual, and may have skewed the outcome. There 
is also the possibility that other/additional exposures modify the effect of day care exposure, for 
example breast feeding has been shown to modify the effect of day care attendance on risk of type 1 
diabetes, where day care attendance was only associated with a decreased risk with increasing 
breast feeding duration, and increased risk with non-breastfed children [72]. Furthermore, the use of 
a proxy measure of infection, may mean that the observed differences in DNA methylation may be 
due to other confounding factors, rather than infection itself i.e. children who attend day care may 
belong to different socio-demographic groups than those who do not, and also have a higher degree 
of social interaction [73]. A selective increase in ALL incidence in children 1-4 years of age has been 
shown during socioeconomic transition [74]. The authors further suggested that difference in 
socioeconomic status (SES) may lead to an increase in a genetically distinct subtype of ALL 
susceptibility, suggesting hyperdiploid ALL as a candidate. Additional studies have proposed that 
DNA methylation may act as a modifiable mechanism by which factors such as SES become 
physically embodied [75], resulting in altered disease risk between SES groups. A spurious result 
must also be considered, given that for day care there were only a small number of individuals 
exposed i.e. only 46/871 were reported to attended day care at 8 month of age. This may also be 
true for maternal radiation exposure were only 29/849 were reported to be exposed. Whilst we 
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 concede that it is possible that these observations may be due to chance, we would argue that the 
perinatal window represents a period of a high degree of plasticity for the developing epigenome 
compared to later time points during childhood and therefore it is plausible that some of the 
observations reported here may be real due to the timing of the exposure. In particular, the 
magnitude and significance of change identified for at least two of the six genes whose methylation 
were influenced by day care attendance (and are altered in ALL) (TMEM132C, -7% (p=0.003); and 
GLB1L, -2% (p=0.03)), implies a true association with this exposure, and potential candidates for 
future studies. Indeed, when using reported cold symptoms in the first 6 months of life as a measure 
of infection, which perhaps may be a less biased, although imperfect measure, we observed a larger 
number of methylation changes (i.e. 75 CpGs as opposed to just 11 for day care attendance). Despite 
a lack of statistically significant overlap between ALL-associated genes, there was a lower degree of 
concordant changes (33%), whereby 6 genes displayed hypomethylation in response to cold 
symptoms and hypermethylation in ALL, supporting the notion that early immune stimulation has a 
protective effect against ALL.        
There are several plausible explanations as to why we did not observe a significant overlap between 
disease associated methylation change and exposure associated methylation changes for all 
exposures assessed. The simplest explanation, that DNA methylation may not be a key mechanism 
linking those particular exposures (i.e. folate supplementation, coffee consumption, and reported 
cold symptoms) and ALL risk. Whilst this is possible, we suggest alternative explanations for these 
findings. In this study we applied the ‘meet in the middle’ approach, due to rarity and difficulty 
obtaining appropriate data and samples within one cohort. The integration and overlap of the data 
sets analysed therefore originated from a combination of prospective and retrospective study 
designs. Moreover, in using data from different studies, the exposed and disease populations are 
likely to be different, which may have influenced study outcomes. The sample size may not have 
been sufficient to detect small exposure-associated methylation changes, thus a larger cohort may 
be needed to detect these small effects, for instance when investigating these associations in larger 
cohorts [54, 55] (Table 3) significant associations were found. 
Here, ALL-associated exposures were measured via questionnaires completed by mothers of the 
offspring from whom DNA methylation data were available. This method of exposure measurement 
is not the most accurate due to reporting bias [76], and therefore it is plausible that we were unable 
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 to detect some methylation changes associated with some of these exposures due to the inaccuracy 
of the exposure data. All of the questions had categorised answers and mothers had to select the 
most appropriate, and no extra/unique data were collected regarding these exposures. In particular, 
the measure used to assess folate status was based on use of supplements. The utility of this 
measure can therefore easily be questioned, as dietary intakes of folate are likely to vary widely 
between individuals. Therefore, there is likely to be a high degree of variation between individuals 
both taking and not taking supplements, which would not have been captured using this method of 
assessment, and thus influence our outcome measure. In addition, the use of cold reporting in the 
first 6 month, whilst an objective measure, does not take into account other infections that may 
have been encountered during early life and consequently influence methylation patterns. 
Therefore, future studies using biomarkers or medical records to measure exposures may help 
improve accuracy of detecting methylation changes in response to some environmental exposures. 
Also, whilst the use of hypergeometric tests gives a statistically based rationale to suggest that a 
higher degree of overlap between ALL and exposure associated genes in not due to a chance finding 
and therefore is likely to be a significant finding, it also could be argued that a biological rationale 
may be equally likely, whereby key methylation changes which result in a functional biological 
outcome are more important than a plethora of changes. For example, whilst the overlap for 
concordant genes for both smoking exposure and ALL was not statistically significant, it is plausible 
that hypermethylation of the CYP1A1 gene caused by smoking during or pre-pregnancy (and 
observed in ALL) has a biologically functional outcome (detoxification of compounds from tobacco 
smoke), which may be in the causal pathway towards disease. The protein encoded by the SEPT9 
gene is involved in cytokinesis, and is crucial for the separation of daughter cells via mediation of 
midbody abscission [77], it has previously been implicated in cancers, including ALL, as well as 
potentially contributing to drug resistance [78]. Hypomethylation, as found in ALL and associated 
with maternal alcohol consumption in this study, could lead to over expression and enhanced cell 
survival. The TBX2 gene encodes a transcriptional repressor involved in the 
determination/maintenance of cell fate [79], found negatively dysregulated in B-cell acute 
lymphoblastic leukaemia [80], as well as in this study shown via hypomethylation in ALL, associated 
with maternal alcohol intake, and sugary caffeinated drink consumption. Using this rationale, it is 
possible that any or all of the concordant changes in methylation we have observed between risk 
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 factors and ALL, may be implicated in disease progression if functionally relevant in the causal 
pathway towards ALL manifestation. 
Due to the difficulties in being able to obtain data and biological samples from childhood ALL cases 
prior to diagnosis there has been limited research investigating the potential mechanistic 
implications of risk exposures on disease development and progression. Here we provide evidence 
to suggest that a range of exposures which have been investigated in the context of ALL risk are 
associated with epigenetic variation. Further evaluation of this variation is required using more 
reliable exposure measurements, through replication in additional cohorts, and implementing causal 
analysis methods. International collaborations will also be key in generating the numbers required to 
capture sufficient ALL cases for a meaningful analysis. Furthermore, the analyses carried out here 
provides supporting evidence for the ability of environmental exposures to drive disease-associated 
changes in DNA methylation. If these changes occur pre-disease (possibly via multiple exposures), 
and in combination with other potential ALL-associated risk factors or ‘hits’, they could explain one 
contributing mechanistic pathway driving ALL disease incidence. Further work aiming to assess 
methylation patterns in ALL cases prior to disease diagnosis is warranted to provide additional 
evidence for a role of DNA methylation in the causal pathway towards disease, and with a view to 
develop predictive biomarkers of disease for high risk groups, and to strengthen the causal 
association between exposures and ALL risk to inform public health policy. 
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Table 1. Number of genes with altered methylation due to an ALL risk exposure (FDR ≤ 0.05) and the overlapping number of genes also observed to have 
altered methylation in ALL disease.  
Exposure 
Number of CpGs 
(hyper/hypo-
methylated) with 
altered 
methylation in 
association with 
exposure 
(FDR ≤ 0.05) 
 
Number of 
gene loci with 
altered 
methylation in 
association 
with exposure 
(FDR ≤ 0.05) 
Number of 
overlapping gene 
loci with 
exposure-
associated 
methylation 
change and 
altered 
methylation in 
ALLa 
Number of overlapping 
gene loci with the same 
direction of methylation 
change (i.e. 
hypo/hypermethylated) 
for  exposure and ALL (% 
concordance)b 
Number of overlapping 
gene loci with exposure-
associated methylation 
change and altered 
methylation in ALL from 
all published literaturea,c 
In utero exposures 
Radiation exposure 288 (140/148) 239 54 (1.69 x 10-8) 40 (74%; 0.001) 156 (0.001) 
Alcohol intake 192 (158/34) 175 33 (3.98 x 10-4) 29 (88%; 0.006) 94 (0.702) 
Sugary caffeinated 
drinks 66 (48/18) 54 12 (7.42 x 10
-3) 10 (83%; 0.045) 30 (0.548) 
Smoking 
throughout 
pregnancy 
Smoking at 3 
months pregnancy 
Smoking pre-
pregnancy 
22 (10/12) 
 
15 (7/8) 
 
7 (4/3) 
13 
 
7 
 
4 
5 (7.11 x 10-3) 
 
3 (2.73 x 10-2) 
 
2 (5.45 x 10-2) 
3 (60%; 0.140) 
 
1 (33%; 0.530) 
 
1 (50%; 0.350) 
10 (0.097) 
 
5 (0.324) 
 
4 (0.094) 
Folic acid 
supplementation 9 (1/8) 7 2 (0.155) 1 (50%; 0.155) 5 (0.324) 
Coffee 
consumption 15 (9/6) 13 1 (0.754) 0 4 (0.981) 
Post-natal exposures 
Reported a cold 
(6 months) 75 (20/55) 60 9 (0.156) 3 (33%; 0.952) 39 (0.085) 
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Attended day 
nursery 
(8 months) 
11 (6/5) 11 6 (2.65 x 10-5) 5 (83%; 0.003) 9 (0.068) 
a P-value for Hypergeometric probability test for number of overlapping gene loci. b P-value for Hypergeometric probability test for number of overlapping 
gene loci with same direction of methylation change. c Published literature identifying ALL disease associated methylation changes (no restrictions on the 
methods used to measure methylation) [1-7]. 
 
 
Table 2. KEGG pathway which may be altered in response to altered methylation observed in children who were exposed in utero to radiation exposure 
(Total number of genes recognised by DAVID n = 79). - = hypomethylated, + hypermethylated. 
KEGG pathway 
term 
Pathway 
name 
Total genes 
altered on 
pathway 
Genes altered 
(- /+ methylation) 
Total 
genes on 
pathway 
P-value 
hsa05146 Amoebiasis 5 LAMA3 (+), LAMA5 (-), 
NFKB1 (+), IL12B (+), 
COL5A1(-) 
106 0.031399 
 
 
Table 3. Number of genes with altered methylation due to ALL risk exposure, reported in published 450K studies (FDR corrected and cell type adjusted) and 
the overlapping number of genes also observed to have altered methylation in ALL.   
Exposure Study (reference) 
Number of CpGs 
(hyper/hypo-methylated) 
with altered methylation in 
association with exposure 
(FDR ≤ 0.05) 
 
Number of gene loci 
with altered 
methylation in 
association with 
exposure 
(FDR ≤ 0.05) 
Number of overlapping gene 
loci with exposure-associated 
methylation change and 
altered methylation in ALL* 
This article is protected by copyright. All rights reserved.
In utero exposures 
Smoking throughout 
pregnancy [8] 6073 (3185/2888) 3176 431 (4.95 x 10
-11) 
Maternal plasma 
folate [9] 443 (27/416) 229 62 (4.32 x 10
-13) 
a P-value for Hypergeometric probability test for number of overlapping gene loci. 
 
Table 4. KEGG pathway which may be altered in response to altered methylation observed in children who were postnatally recorded as having a cold (6 
months) (Total number of genes recognised by DAVID n = 12). - = hypomethylated, + hypermethylated. 
KEGG pathway 
term 
Pathway 
name 
Total genes 
altered on 
pathway 
Genes altered 
(- /+ methylation) 
Total 
genes on 
pathway 
P-value 
hsa04010 MAPK 
signalling 
pathway 
4 MAP3K7 (-), MAPK1 (-), ATF4 
(-), ARRB1(-) 
267 0.017247 
 
 
 
 
1. Figueroa, M.E., et al., Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest, 2013. 123(7): p. 3099-111. 
2. Sandoval, J., et al., Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia. Br J Haematol, 2013. 
160(3): p. 406-9. 
3. Almamun, M., et al., Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia. 
Epigenetics, 2015. 10(9): p. 882-90. 
4. Schafer, E., et al., Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting. Blood, 2010. 
115(23): p. 4798-809. 
5. Wong, N.C., et al., A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics, 2012. 7(6): p. 535-41. 
This article is protected by copyright. All rights reserved.
6. Dunwell, T., et al., A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol Cancer, 2010. 9: p. 
44. 
7. Davidsson, J., et al., The DNA methylome of pediatric acute lymphoblastic leukemia. Hum Mol Genet, 2009. 18(21): p. 4054-65. 
8. Joubert, Bonnie R., et al., DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis. The 
American Journal of Human Genetics, 2016. 98(4): p. 680-696. 
9. Joubert, B.R., et al., Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns. Nat Commun, 
2016. 7: p. 10577. 
 
This article is protected by copyright. All rights reserved.
